Company Analysis

Insmed Incorporated (INSM)

Nasdaq: INSM · Pharmaceutical Preparations · Bridgewater, NJ · filing with the SEC since 2000
Grade6.0
◀ Past 7.0● Present 5.4▶ Future 5.8
1 est.

Who runs Insmed Incorporated

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Lewis William
Chair and CEO. First filing Sep 2012, latest Jul 24, 2026, 62 filings in all.
Officers reporting now
7
of 16 people with a filing in the last fifteen months
Directors reporting now
9
28 people on the record since 2006
Officerssales are open-market, Oct 20, 2025 to Oct 20, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Adsett RogerChief Operating OfficerOct 2016Aug 12, 202610 · $48.3M
Flammer Martina M.D.Chief Medical OfficerDec 2019Aug 7, 202640 · $23.3M
Lewis WilliamChair and CEOSep 2012Jul 24, 202674 · $32.8M
Smith Michael AlexanderChief Legal OfficerJul 2021Jun 24, 202620 · $14.0M
Butera SamueleSVP, GM, Global RespiratoryJun 2026Jun 24, 2026none
Bonstein SaraChief Financial OfficerFeb 2020Jun 5, 20266 · $2.1M
Schaeffer Orlov S NicoleChief People Strategy OfficerJun 2014Jan 6, 20269 · $21.1M
Directorssales are open-market, Oct 20, 2025 to Oct 20, 2026
NameRoleFirst filingLatest filingSales, 12 months
Hudson PauldirectorOct 2026Oct 20, 2026none
Koppikar UtpaldirectorOct 2026Oct 20, 2026none
Brennan David RdirectorJun 2014Sep 11, 20261 · $3.1M
Sharoky Melvin MddirectorMay 2006Aug 19, 20262 · $4.7M
Anderson Elizabeth MdirectorNov 2018May 15, 20262 · $3.0M
Desjardins ClarissadirectorNov 2019May 15, 2026none
Lee LeodirectorMay 2018May 15, 20265 · $14.7M
Schafer CaroldirectorApr 2020May 15, 2026none
Mcgirr David W JdirectorNov 2013Feb 11, 2026none
Earlier names on the record12, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton INSM · research, not advice